Low-dose prednisone accounts for a transient reduction on CD4+ and CD8+ T cells in renal transplant patients under triple therapy

Transplant Proc. 2002 Dec;34(8):3183-4. doi: 10.1016/s0041-1345(02)03596-0.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Azathioprine / pharmacokinetics
  • Azathioprine / therapeutic use
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Erythrocytes / immunology
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Lymphocyte Count*
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Prednisone / pharmacokinetics
  • Prednisone / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Prednisone